Debbie's Place

A Patient's Point of View

2-AG/ 2-ARACHIDONOYLGLYCEROL

 2-AG/ 2-ARACHIDONOYLGLYCEROL endocannabinoid, CB1 & CB 2 agonist

 

Phytocannabinoids        (news – undated)

http://www.news-medical.net/health/Phytocannabinoids.aspx

 

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain (abst – 1995)                              http://www.sciencedirect.com/science/article/pii/S0006291X85724370

 

Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand                       (full – 1997)  http://www.druglibrary.org/crl/receptors/endogenous/Goparahu%20et.al%2098%202-  AG_%20FEBSLet.pdf

 

A Second Endogenous Cannabinoid That Modulates Long-term Potentiation. (abst – 1997)                                http://www.ncbi.nlm.nih.gov/pubmed/9285589

 

Brain Chemicals Mimic Marijuana         (news – 1997)

http://www.ukcia.org/research/anandami.php

 

 

2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist: identification as one of the major species of monoacylglycerols in various rat tissues, and evidence for its generation through Ca2.-dependent and -independent mechanisms                                                                    (full – 1998)  http://www.druglibrary.org/crl/receptors/endogenous/Kondo%20et.al%2098%20Generation_%20FEBSLet.  pdf

 

2-Arachidonoyl-glycerol as an “endocannabinoid”: limelight for a formerly neglected metabolite.     (abst – 1998)              http://www.ncbi.nlm.nih.gov/pubmed/9526090

 

Evidence That the Cannabinoid CB1 Receptor Is a 2-Arachidonoylglycerol Receptor (full – 1999)                           http://www.jbc.org/content/274/5/2794.long

 

Synthesis and Biological Activities of 2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, and Its Metabolically Stable Ether-linked Analogues (full – 2000)                        http://cpb.pharm.or.jp/cpb/200007/C07_0903.pdf

 

Endocannabinoids control spasticity in a multiple sclerosis model        (full – 2000)  http://www.fasebj.org/cgi/reprint/00-  0399fjev1?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=cannabis&andorexactfulltext=and&sear chid=1&FIRSTINDEX=10&sortspec=relevance&resourcetype=HWCIT

 

Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.                           (full – 2000)  http://molpharm.aspetjournals.org/content/57/5/1045.long

 

Endocannabinoids and Vascular Function       (full – 2000)

http://jpet.aspetjournals.org/content/294/1/27.long

 

2-Arachidonoylglycerol and the cannabinoid receptors.         (abst – 2000)

http://www.ncbi.nlm.nih.gov/pubmed/11106784

 

Cardiovascular effects of endocannabinoids–the plot thickens.        (abst – 2000)  http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=10785543&dopt=abstrac tplus

 

Endogenous cannabinoids and appetite.         (abst – 2000)

http://www.ncbi.nlm.nih.gov/pubmed/19087417

 

Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. (full – 2001)                               http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572991/?tool=pubmed

 

Endogenous cannabinoids mediate hypotension after experimental myocardial infarction (full – 2001)  http://content.onlinejacc.org/cgi/content/full/38/7/2048?maxtoshow=&hits=80&RESULTFORMAT=&fullt  ext=cannabinoid&searchid=1&FIRSTINDEX=560&resourcetype=HWCIT

 

Inhibition of Rat C6 Glioma Cell Proliferation by Endogenous and Synthetic Cannabinoids. Relative Involvement of Cannabinoid and Vanilloid Receptors (full – 2001)                             http://jpet.aspetjournals.org/content/299/3/951.full

 

Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation                                         (full – 2001)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572987/?tool=pmcentrez

 

2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor (full – 2001)                             http://www.ncbi.nlm.nih.gov/pmc/articles/PMC31108/

 

Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts                  (full – 2001)  http://cardiovascres.oxfordjournals.org/content/55/3/619.full?sid=750cba66-d3d1-484d-96e8-  04975ba34325

 

The neurobiology and evolution of cannabinoid signalling         (abst – 2001)  http://rstb.royalsocietypublishing.org/content/356/1407/381.abstract?ijkey=3aad97283bf56bae0ada89fe6c2  5ef27a702e9ba&keytype2=tf_ipsecsha

 

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. (abst – 2001)                             http://www.ncbi.nlm.nih.gov/pubmed/11586361

 

Sourcing the Code: Searching for the Evolutionary Origins of Cannabinoid Receptors, Vanilloid Receptors, and Anandamide                        (full – 2002)

http://www.cannabis-med.org/data/pdf/2002-01-3.pdf

 

Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2- AG) in immune cells                                         (full – 2002)  http://www.fasebj.org/cgi/content/full/15/12/2171?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=  cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=10&sortspec=relevance&resourcetype=H   WCIT

 

The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.                                (full – 2002)  http://jpet.aspetjournals.org/content/300/1/34.long

 

Comparison of the enzymatic stability and intraocular pressure effects of 2- arachidonylglycerol and noladin ether, a novel putative endocannabinoid.                                                           (full – 2002)  http://www.iovs.org/content/43/10/3216.full

 

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.                                            (full – 2002)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573386/?tool=pubmed

 

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.                                     (abst – 2002)        http://www.ncbi.nlm.nih.gov/pubmed/12393235

 

Endocannabinoids and related fatty acid derivatives in pain modulation.      (abst – 2002)

 

http://www.ncbi.nlm.nih.gov/pubmed/12505698

 

Endocannabinoids protect the rat isolated heart against ischaemia       (full – 2003)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573907/?tool=pmcentrez

 

Chronic Morphine Modulates the Contents of the Endocannabinoid, 2-Arachidonoyl Glycerol, in Rat Brain                                   (full – 2003)  http://www.nature.com/npp/journal/v28/n6/full/1300117a.html

 

Role of Endogenous Cannabinoids in Synaptic Signaling       (full – 2003)  http://physrev.physiology.org/cgi/content/full/83/3/1017?maxtoshow=&hits=80&RESULTFORMAT=&ful  ltext=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT

 

The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy                                           (full – 2003)  http://jpet.aspetjournals.org/content/307/1/129.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=  cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT

 

Manipulation of the endocannabinoid system by a general anaesthetic.      (full – 2003)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573927/?tool=pubmed

 

Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. (abst – 2003)                            http://www.ncbi.nlm.nih.gov/pubmed/12447606

 

Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain.                            (abst – 2003)         http://www.ncbi.nlm.nih.gov/pubmed/12914975

 

The endocannabinoid system: a general view and latest additions         (full – 2004)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574255/?tool=pmcentrez

 

New perspectives in the studies on endocannabinoid and cannabis: 2- arachidonoylglycerol as a possible novel mediator of inflammation                                                                (full – 2004)  https://www.jstage.jst.go.jp/article/jphs/96/4/96_4_367/_pdf

 

2-Arachidonoylglycerol A Novel Inhibitor of Androgen-Independent Prostate Cancer Cell Invasion                             (full – 2004)  http://cancerres.aacrjournals.org/cgi/content/full/64/24/8826?ijkey=951f5f9d238bdf059cf30ee2be3a5a31aa  f2b094

 

The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.     (abst – 2004)         http://www.ncbi.nlm.nih.gov/pubmed/15159678

 

A new class of inhibitors of 2-arachidonoylglycerol hydrolysis and invasion of prostate cancer cells (full – 2005)                 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1450257/

 

2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells (full – 2005)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1134878/

 

 

Analgesia through endogenous cannabinoids      (full – 2005)  http://www.cmaj.ca/cgi/content/full/173/4/357?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=end  ocannabinoid&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=date&resourcetype=HW   CIT

 

CB1 cannabinoid receptor-mediated modulation of food intake in mice     (full – 2005)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576140/?tool=pmcentrez

 

Effects of cannabinoids on colonic muscle contractility and tension in guinea pigs. (full – 2005)                           https://www.jstage.jst.go.jp/article/jnms/72/1/72_1_43/_pdf

 

Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders.                                  (full – 2005)  http://www.jleukbio.org/content/78/1/231.long

 

The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines.                                 (abst – 2005)  http://lib.bioinfo.pl/pmid:16364651

 

Finding of endocannabinoids in human eye tissues: implications for glaucoma. (abst – 2005)                           http://www.ncbi.nlm.nih.gov/pubmed/15823551

 

Body’s Own Marijuana-Like Compounds Are Crucial For Stress-Induced Pain Relief (news – 2005)                               http://www.sciencedaily.com/releases/2005/06/050628064435.htm

 

Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and ß-Pancreatic Cells and in Obesity and Hyperglycemia                                     (full – 2006)  http://jcem.endojournals.org/cgi/content/full/91/8/3171?ijkey=83a68cef202eafe129332eda53eee8eb613499 82

 

Endocannabinoids, feeding and suckling – from our perspective      (full – 2006)

http://www.nature.com/ijo/journal/v30/n1s/full/0803274a.html

 

Not Too Excited? Thank Your Endocannabinoids         (full – 2006)

http://www.sciencedirect.com/science/article/pii/S0896627306005927

 

Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection                                    (full – 2006)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1458883/?tool=pmcentrez

 

Weight Control in Individuals With Diabetes       (full – 2006)  http://care.diabetesjournals.org/content/29/12/2749.full?maxtoshow=&hits=80&RESULTFORMAT=&full text=cannabis&searchid=1&FIRSTINDEX=2000&resourcetype=HWCIT

 

A new strategy to block tumor growth by inhibiting endocannabinoid inactivation. (full – 2006)                             http://www.fasebj.org/content/early/2004/10/02/fj.04-1754fje.long

 

Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2- Arachidonoylglycerol in Oxazolone-Induced Contact Dermatitis in Mice                                             (full – 2006)  http://www.jimmunol.org/content/177/12/8796.full

 

Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions. (abst – 2006)               http://www.ncbi.nlm.nih.gov/pubmed/16506408

 

Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2- arachidonoylglycerol.        (abst – 2006)       http://www.ncbi.nlm.nih.gov/pubmed/16949718

 

Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice.                        (abst – 2006)  http://www.ncbi.nlm.nih.gov/pubmed/16310817

 

Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.                                         (abst – 2006)       http://www.ncbi.nlm.nih.gov/pubmed/16678907

 

The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines.                                  (abst – 2006)  http://www.ncbi.nlm.nih.gov/pubmed/16364651

 

The CB1 Cannabinoid Receptor Mediates Excitotoxicity-induced Neural Progenitor Proliferation and Neurogenesis                                  (full – 2007)       http://www.jbc.org/content/282/33/23892.full

 

Endocannabinoids and the haematological system       (full – 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190025/?tool=pmcentrez

 

Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon                              (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755791/?tool=pmcentrez

 

Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism                                        (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565646/?tool=pubmed

 

Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth : RECRUITMENT OF Fas AND Fas LIGAND TO LIPID RAFTS                                                 (full – 2007)

http://www.jbc.org/content/282/17/13098.full

 

Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus.

(full – 2007)         http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2042935/?tool=pubmed

 

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury (full – 2007)                               http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228252/?tool=pmcentrez

 

Endocannabinoids block status epilepticus in cultured hippocampal neurons (full – 2007)                            http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2617750/?tool=pmcentrez

 

 

Chronologically overlapping occurrences of nicotine-induced anxiety- and depression- related behavioral symptoms: effects of anxiolytic and cannabinoid drugs                                    (full – 2007)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075518/?tool=pubmed

 

2-AG + 2 new players = forecast for therapeutic advances.      (full – 2007)  http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VRP-4RFCCVN-  4&_user=10&_coverDate=12%2F26%2F2007&_rdoc=1&_fmt=high&_orig=gateway&_origin=gateway&

_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=       9ee  f728e35c89b5764ef2d27c0cdffe9&searchtype=a

 

CB2 receptors in the brain: role in central immune function      (full – 2007)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219530/?tool=pmcentrez

 

Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth    (full – 2007)

http://www.jbc.org/content/282/17/13098.full

 

Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher                       (interview – 2007)  http://www.jleukbio.org/cgi/content/full/82/6/1390?maxtoshow=&hits=80&RESULTFORMAT=&fulltext

=cannabinoid&searchid=1&FIRSTINDEX=880&resourcetype=HWCIT

 

In Vitro Anticonvulsant Action of 2-Arachidonyl Glycerol            (abst – 2007)  http://www.doaj.org/doaj?func=abstract&id=463469&q1=anandamide&f1=all&b1=and&q2=&f2=all&rec No=29&uiLanguage=en

 

Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue. (abst – 2007)                               http://www.ncbi.nlm.nih.gov/pubmed/17419758

 

The endocannabinoids anandamide and 2-arachidonoylglycerol inhibit cholinergic contractility in the human colon.                                         (abst – 2007)  http://www.ncbi.nlm.nih.gov/pubmed/17706636

 

The endocannabinoid system        (news – 2007)

http://www.xagena.it/news/medicinenews_net_news/27e9efa7a852bcaa4d9fe0791d2d37b1.html

 

The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling.                       (full – 2008)        http://www.fasebj.org/cgi/content/full/22/1/285

 

Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells        (full – 2008)  http://www.jimmunol.org/cgi/content/full/181/9/6406?maxtoshow=&hits=80&RESULTFORMAT=&fullte  xt=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT

 

Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling.                             (full – 2008)  http://www.fasebj.org/content/22/10/3685.long

 

Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages                                  (full – 2008)  http://cardiovascres.oxfordjournals.org/content/81/4/805.full?sid=7d2438c4-a727-410f-870d-  4a971695b4fb

 

Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation   (full – 2008)               http://www.jbc.org/content/283/33/22601.full

 

Endocannabinoids and nutrition.         (full – 2008)

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01687.x/full

 

Activating Parabrachial Cannabinoid CB1 Receptors Selectively Stimulates Feeding of Palatable Foods in Rats                                         (full – 2008)  http://www.jneurosci.org/cgi/content/full/28/39/9702?maxtoshow=&hits=80&RESULTFORMAT=&fullte   xt=cannabinoid&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT

 

Cannabinoid receptors and the regulation of bone mass       (full – 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219540/?tool=pmcentrez

 

Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin- Induced Cardiotoxicity                     (full – 2008)       http://content.onlinejacc.org/cgi/content/full/50/6/528

 

Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet                             (full – 2008)      http://www.nature.com/oby/journal/v16/n3/full/oby2007106a.html

 

Endocannabinoids and the Control of Energy Homeostasis        (full – 2008)

http://www.jbc.org/content/283/48/33021.full?sid=931583b1-e797-43e0-8296-7fd75bb49403

 

The influence of mast cell mediators on migration of SW756 cervical carcinoma cells. (full – 2008)                            https://www.jstage.jst.go.jp/article/jphs/106/2/106_FP0070736/_pdf

 

Endocannabinoids and nutrition.       (full – 2008)

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01687.x/pdf

 

Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon.                              (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755791/?tool=pubmed

 

Mechanisms for Recycling and Biosynthesis of Endogenous Cannabinoids Anandamide and 2-Arachidonylglycerol                     (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2581634/?tool=pmcentrez

 

Dysregulation of the endocannabinoid system in obesity.     (abst – 2008)

http://www.ncbi.nlm.nih.gov/pubmed/18426509

 

Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets.                                    (abst – 2008)        http://www.ncbi.nlm.nih.gov/pubmed/18343566

 

Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. (abst – 2008)                              http://www.ncbi.nlm.nih.gov/pubmed/18535023

 

Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum.                           (abst – 2008)        http://www.ncbi.nlm.nih.gov/pubmed/18204441

 

Understanding the effects of endogenous cannabinoids       (news – 2008)

http://arstechnica.com/science/news/2008/11/understanding-the-effects-of-endogenous-cannabinoids.ars

 

Marijuana-Inspired Painkiller? New Chemical Pathway Discovered         (news – 2008)

http://www.sciencedaily.com/releases/2008/11/081123150249.htm

 

LSUHSC research reports new method to protect brain cells from diseases like Alzheimer’s  (news – 2008)                        http://www.eurekalert.org/pub_releases/2008-08/lsuh-lrr082008.php

 

Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner                                             (full – 2009)  http://cardiovascres.oxfordjournals.org/content/85/1/56.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb

 

Changes in the Endocannabinoid System May Give Insight into new and Effective Treatments for Cancer                                 (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791688/?tool=pmcentrez

 

Endocannabinoids and Their Receptors as Targets for Obesity Therapy        (full – 2009)

http://endo.endojournals.org/cgi/content/full/150/6/2531#top

 

Endocannabinoid-mediated control of synaptic transmission.       (full – 2009)

http://physrev.physiology.org/content/89/1/309.long

 

Lipid rafts regulate 2-arachidonoylglycerol metabolism and physiological activity in the striatum      (full – 2009)          http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2009.05948.x/full

 

Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects    (full – 2009)                           http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2605181/

 

Neuropathic Pain and Endocannabinoid-Degradation Blockade        (full – 2009)

http://jpet.aspetjournals.org/content/330/3/669.1.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17

 

Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. (full – 2009)

http://jpet.aspetjournals.org/content/330/3/902.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17

 

Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.                                     (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716432/?tool=pubmed

 

Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain                                          (full – 2009)  http://www.molecularpain.com/content/5/1/35

 

From endocannabinoid profiling to ‘endocannabinoid therapeutics’.       (abst – 2009)

http://www.ncbi.nlm.nih.gov/pubmed/19497779

 

Circulating endocannabinoid concentrations during orthostatic stress      (abst – 2009)

www.ncbi.nlm.nih.gov/pubmed/19756829

 

The endocannabinoid 2-arachidonoylglycerol promotes sperm developement through activation of cannabinoid-2 receptors                              (abst – 2009)

http://www.cannabis-med.org/index.php?tpl=cannabinoids&id=238&lng=en&red=cannabinoidslist

 

Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats.                                        (abst – 2009)         http://www.ncbi.nlm.nih.gov/pubmed/19602424

 

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2                             (full – 2010)  http://pharmrev.aspetjournals.org/content/62/4/588.full.pdf+html

 

Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.                                  (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848893/?tool=pubmed

 

Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA.           (full – 2010)      http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055456/

 

Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.    (full – 2010)              http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906112/

 

Antitumorigenic Effects of Cannabinoids beyond Apoptosis      (full – 2010)

http://jpet.aspetjournals.org/content/332/2/336.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17

 

Endocannabinoid Overload         (full – 2010)

http://molpharm.aspetjournals.org/content/78/6/993.full

 

Maternal Dietary Fat Determines Metabolic Profile and the Magnitude of Endocannabinoid Inhibition of the Stress Response in Neonatal Rat Offspring (full – 2010)

http://endo.endojournals.org/content/151/4/1685.full?sid=f9729cff-d221-42d4-81d8-8545db5df878

 

Cyclooxygenase-2 Mediates Anandamide Metabolism in the Mouse Brain      (full – 2010)

http://jpet.aspetjournals.org/content/335/2/380.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17

 

Cannabinoid Receptors as Target for Treatment of Osteoporosis: A Tale of Two Therapies    (full – 2010)                     http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001217/?tool=pubmed

 

Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients                              (full – 2010)  http://www.lipidworld.com/content/9/1/43

 

Cannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsy.                                  (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871782/?tool=pubmed

 

Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls (full – 2010)                             http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2010.00787.x/full

 

Energetic Metabolism and Human Sperm Motility: Impact of CB1 Receptor Activation (full – 2010)                            http://endo.endojournals.org/content/151/12/5882.full

 

Endogenous cannabinoid signaling is essential for stress adaptation      (full – 2010)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889099/?tool=pmcentrez

 

Endocannabinoid signalling: has it got rhythm?        (full – 2010)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931554/?tool=pubmed

 

The endocannabinoid 2-arachidonoyl-glycerol controls odor sensitivity in larvae of Xenopus laevis.                              (full – 2010)       http://www.jneurosci.org/content/30/26/8965.long

 

Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.                                (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868848/?tool=pubmed

 

The endocannabinoid system as a target for the treatment of neurodegenerative disease (full – 2010)                               http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931550/?tool=pubmed

 

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors.                             (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970523/?tool=pubmed

 

A model of endocannabinoid 2-AG-mediated depolarization-induced suppression of inhibition                        (article – 2010)       http://www.biomedcentral.com/1471-2202/11/S1/P189

 

From Fertilisation to Implantation in Mammalian Pregnancy—Modulation of Early Human Reproduction by the Endocannabinoid System                   (link to PDF – 2010)  http://www.mdpi.com/1424-8247/3/9/2910

 

Endocannabinoids and Schizophrenia      (link to PDF – 2010)

http://www.mdpi.com/1424-8247/3/10/3101

 

The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury.                                            (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20156559

 

The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration.    (abst – 2010)                              http://www.ncbi.nlm.nih.gov/pubmed/20875047

 

Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?                              (abst – 2010)  http://www.unboundmedicine.com/medline/ebm/record/20512266/abstract/%5BPharmacological_exploitat ion_of_the_endocannabinoid_system:_new_perspectives_for_the_treatment_of_depression_and_anxiety_d isorders%5D_

 

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors                              (abst – 2010)  http://www.nature.com/neuro/journal/v13/n8/full/nn.2601.html

 

Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.                              (abst – 2010)          http://www.ncbi.nlm.nih.gov/pubmed/19840245

 

Endogenous cannabinoids in liver disease: Many darts for a single target       (abst – 2010)

http://www.ncbi.nlm.nih.gov/pubmed/19758727

 

Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea– specific role of oleoylethanolamide.                                  (abst – 2010)  http://www.ncbi.nlm.nih.gov/pubmed/20429051

 

Receptors triggered by pot may lessen hit from chronic stress        (news – 2010)

http://arstechnica.com/science/2010/05/brains-endogenous-cannabinoids-lessen-impact-of-stress/

 

Painkilling System in Brain: Too Much of a Good Thing?          (news – 2010)

http://www.sciencedaily.com/releases/2010/08/100824151036.htm

 

Drugs that reduce activity of ABDH6 enzyme can prevent brain damage: Study (news – 2010)

http://www.news-medical.net/news/20100807/Drugs-that-reduce-activity-of-ABDH6-enzyme-can-prevent-  brain-damage-Study.aspx?page=2

 

Newly discovered mechanism controls levels and efficacy of a marijuana-like substance in the brain (news – 2010)

http://www.eurekalert.org/pub_releases/2010-08/uow-ndm080610.php

 

Anti-proliferative Effect of a Putative Endocannabinoid, 2-Arachidonylglyceryl Ether in Prostate Carcinoma Cells                                           (full – 2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039283/?tool=pmcentrez

 

The endocannabinoid system and cancer: therapeutic implication         (full – 2011)

http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01327.x/full

 

Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism.                                       (full – 2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933347/?tool=pubmed

 

Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice                                     (full – 2011)  http://www.nutritionandmetabolism.com/content/8/1/51

 

The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans

(full – 2011)         http://www.lipidworld.com/content/10/1/129

 

Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. (full – 2011)                          http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048484/?tool=pubmed

 

Targeting the CB2 cannabinoid receptor in osteoporosis        (full – 2011)

http://www.expert- reviews.com/doi/full/10.1586/eem.11.2?prevSearch=Keyword%253A%2528%2522cannabinoid%2522%2  529&searchHistoryKey=

 

The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of

2‐arachidonoylglycerol signalling through cannabinoid receptors         (full – 2011)

http://onlinelibrary.wiley.com/doi/10.1111/j.1748-1716.2011.02280.x/full

 

Dual inhibition of alpha/beta hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons.                           (full – 2011)  http://www.jbc.org/content/early/2011/06/10/jbc.M110.202853.long

 

Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation.                       (full – 2011)        http://www.fasebj.org/content/25/8/2711.long

 

Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy.                             (full – 2011)      http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161308/

 

Cannabinoid exposure during zebra finch sensorimotor vocal learning persistently alters expression of endocannabinoid signaling elements and acute agonist responsiveness (full – 2011)                          http://www.biomedcentral.com/1471-2202/12/3

 

Endogenous Cannabinoid Production in the Rat Female Reproductive Tract Is Regulated by Changes in the Hormonal Milieu                                   (link to PDF – 2011)

http://www.mdpi.com/1424-8247/4/6/933

 

The Endogenous Cannabinoid 2-Arachidonoylglycerol Is Intravenously Self- Administered by Squirrel Monkeys                                                    (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21562266/abstract/The_Endogenous_Cannabinoid

_2_Arachidonoylglycerol_Is_Intravenously_Self_Administered_by_Squirrel_Monkeys_

 

Effect of capacitation on the endocannabinoid system of mouse sperm.      (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21723369

 

Chemoenzymatic synthesis of 2-arachidonoylglycerol, an endogenous ligand for cannabinoid receptors                             (abst – 2011)  http://www.sciencedirect.com/science/article/pii/S0040403911000748

 

Administration of 2-arachidonoylglycerol ameliorates both acute and chronic Experimental Autoimmune Encephalomyelitis                                                       (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21406188/abstract/Administration_of_2_arachidon  oylglycerol_ameliorates_both_acute_and_chronic_Experimental_Autoimmune_Encephalomyelitis_

 

The Effect of Hypoxia on G Protein Coupled (CB1) Receptor Gene Expression in Cortical B50 Neurons in Culture                                (abst – 2011)  http://www.maxwellsci.com/jp/abstract.php?jid=BJPT&no=92&abs=05

 

Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults. (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21256197/abstract/Endocannabinoid_2_arachidono  ylglycerol_protects_neurons_against_%CE%B2_amyloid_insults_

 

Alteration of the Endocannabinoid System In Mouse Brain During Prion Disease. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21195746/abstract/Alteration_of_the_Endocannabi  noid_System_In_Mouse_Brain_During_Prion_Disease_

 

Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone.                                (abst – 2011)         http://www.ncbi.nlm.nih.gov/pubmed/21875957

 

The endocannabinoid system in the cancer therapy: an overview.         (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21428888

 

Cannabinoid Receptor 2 Is Critical for the Homing and Retention of Marginal Zone B Lineage Cells and for Efficient T-Independent Immune Responses                                           (abst – 2011)  http://www.jimmunol.org/content/187/11/5720.abstract?sid=590f7819-f39b-4214-abca-07231b51da55

 

The major central endocannabinoid directly acts at GABA(A) receptors.      (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/22025726

 

2-Arachidonoylglycerol (2-AG) Induces Corneal Epithelial Cell Migration via Cannabinoid CB1 Receptors                                                        (abst – 2011)  http://abstracts.iovs.org/cgi/content/abstract/52/6/1995?maxtoshow=&hits=80&RESULTFORMAT=&fullt ext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT

 

Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals.                                   (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21109417

 

Increment of hypothalamic 2-arachidonoylglycerol induces the preference for a high-fat diet via activation of cannabinoid 1 receptors                                       (abst – 2011)

 

http://www.unboundmedicine.com/medline/ebm/record/20817042/abstract/Increment_of_hypothalamic_2_  arachidonoylglycerol_induces_the_preference_for_a_high_fat_diet_via_activation_of_cannabinoid_1_rece  ptors_

 

Endogenously generated 2-arachidonoylglycerol plays an inhibitory role in bombesin- induced activation of central adrenomedullary outflow in rats.                                      (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21371452

 

Endocannabinoid CB1 receptors modulate visual output from the thalamus. (abst – 2011)                            http://www.ncbi.nlm.nih.gov/pubmed/21773721

 

Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines.                                   (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21995886

 

The endocannabinoid system in the cancer therapy: an overview.      (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21428888

 

Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro (abst – 2011)                             http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01519.x/abstract

 

Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.                                          (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21145341/abstract/Inhibition_of_endocannabinoid

_catabolic_enzymes_elicits_anxiolytic_like_effects_in_the_marble_burying_assay_

 

Cannabinoid-2 Receptor Activation Protects against Infarct and Ischemia/Reperfusion Heart Injury.                            (abst – 2011)      http://www.ncbi.nlm.nih.gov/pubmed/22113346

 

Effect of an Acute Consumption of a Moderate Amount of Ethanol on Plasma Endocannabinoid Levels in Humans                                            (abst – 2011)  http://alcalc.oxfordjournals.org/content/47/3/226.short?rss=1

 

Intense exercise increases circulating endocannabinoid and BDNF levels in humans— Possible implications for reward and depression                          (abst – 2011)  http://www.psyneuen-journal.com/article/PIIS0306453011002873/abstract?rss=yes

 

New metabolic pathway for controlling brain inflammation           (news – 2011)  http://www.news-medical.net/news/20111021/New-metabolic-pathway-for-controlling-brain-  inflammation.aspx

 

Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids

(full – 2012)           http://link.springer.com/article/10.1007/s12035-012-8299-0/fulltext.html

 

Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. (full – 2012)                               http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458187/

 

Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full – 2012)                           http://rstb.royalsocietypublishing.org/content/367/1607/3193.long

 

Serum contents of endocannabinoids are correlated with blood pressure in depressed women.          (full – 2012)         http://www.lipidworld.com/content/pdf/1476-511X-11-32.pdf

 

Cannabinoid Receptor 2-Mediated Attenuation of CXCR4-Tropic HIV Infection in Primary CD4+ T Cells                                         (full – 2012)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033961

 

The role of CB2 receptor ligands in human eosinophil function        (full – 2012)

http://www.biomedcentral.com/content/pdf/2050-6511-13-S1-A13.pdf

 

Endocannabinoids Stimulate Human Melanogenesis via Type-1 Cannabinoid Receptor (full – 2012)                              http://www.jbc.org/content/early/2012/03/19/jbc.M111.314880.full.pdf+html

 

Hypothalamic 2-arachidonoylglycerol regulates multistage process of high-fat diet preferences.                             (full – 2012)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0038609

 

Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells                                (full – 2012)  http://endo.endojournals.org/content/153/1/29.full

 

Over-Expression of Monoacylglycerol Lipase (MGL) in Small Intestine Alters Endocannabinoid Levels and Whole Body Energy Balance, Resulting in Obesity. (full – 2012)                             http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429419/

 

Role of cannabinoids in the regulation of bone remodeling        (full – 2012)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499879/

 

Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors.                                  (full – 2012)  http://www.jbc.org/content/early/2012/07/11/jbc.M112.346296.full.pdf+html

 

Endocannabinoids measurement in human saliva as potential biomarker of obesity. (full – 2012)                         http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409167/?tool=pubmed

 

Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia.                                        (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/

 

Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids                                   (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493609/

 

Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues                       (full – 2012)

 

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483099/

 

Review article: Endocannabinoids in neuroendopsychology: multiphasic control of mitochondrial function                              (full – 2012)  http://rstb.royalsocietypublishing.org/content/367/1607/3342.full?sid=dd42995f-c629-4f8c-86a0-  5e962e352fda

 

The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting CB receptors.                                      (full – 2012)  http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02059.x/full

 

Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery                        (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/

 

So what do we call GPR18 now?        (full – 2012)

http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01731.x/full

 

Diet-dependent modulation of hippocampal expression of endocannabinoid signaling- related proteins in cannabinoid antagonist-treated obese rats.                                         (full – 2012)  http://onlinelibrary.wiley.com/doi/10.1111/ejn.12012/full

 

GPR18 in microglia: implications for the CNS and endocannabinoid system signaling (full – 2012)                            http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02019.x/full

 

A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer’s Disease                                     (full – 2012)

http://download.cell.com/cell-reports/mmcs/journals/2211-1247/PIIS2211124712001258.mmc2.pdf

 

Monoacylglycerol lipase is a new therapeutic target for Alzheimer’s disease (full – 2012)                             http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513645/

 

The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full – 2012)                              http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02175.x/full

 

Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome      (full – 2012)             http://www.nature.com/ncomms/journal/v3/n9/full/ncomms2045.html

 

Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3      (full – 2012)                                  http://www.ojrd.com/content/7/1/59

 

Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat            (full – 2012)

http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02179.x/full

 

Autocrine Endocannabinoid Signaling Through CB1 Receptors Potentiates OX1 Orexin Receptor Signaling.                          (full – 2012)  http://molpharm.aspetjournals.org/content/early/2012/12/11/mol.112.080523.long

 

Bidirectional regulation of endocannabinoid signaling in the amygdala contributes to activation and adaptation of the stress response                                 (link to PDF – 2012)  http://www.doaj.org/doaj?func=abstract&id=1152480&q1=cannabinoid&f1=all&b1=and&q2=&f2=all&re cNo=4&uiLanguage=en

 

Critical role of the endocannabinoid system in mediating rapid glucocorticoid effects on memory for emotionally arousing experiences                             (link to PDF – 2012)  http://www.doaj.org/doaj?func=abstract&id=1152481&q1=cannabinoid&f1=all&b1=and&q2=&f2=all&re cNo=3&uiLanguage=en

 

Endocannabinoids in stressed humans         (link to PDF – 2012)  http://www.doaj.org/doaj?func=abstract&id=1152482&q1=cannabinoid&f1=all&b1=and&q2=&f2=all&re cNo=2&uiLanguage=en

 

Glucocorticoid-endocannabinoid interaction in cardiac surgical patients: relationship to early cognitive dysfunction and late depression                                   (abst – 2012)  http://www.degruyter.com/abstract/j/revneuro.2012.23.issue-5-6/revneuro-2012-0058/revneuro-2012-  0058.xml?rskey=jSEJyD&result=10&q=cannabinoid

 

Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice, and induces weight gain and inflammation in mice.            (abst – 2012)                  http://www.ncbi.nlm.nih.gov/pubmed/22883314

 

Activation of Type 5 Metabotropic Glutamate Receptors and Diacylglycerol Lipase-α Initiates 2-Arachidonoylglycerol Formation and Endocannabinoid-Mediated Analgesia. (abst – 2012)                             http://www.ncbi.nlm.nih.gov/pubmed/22787031

 

Monoacylglycerol lipase – a target for drug development?        (abst – 2012)

http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01950.x/abstract

 

Dynamic changes to the endocannabinoid system in models of chronic pain (abst – 2012)                          http://www.ncbi.nlm.nih.gov/pubmed/23108548

 

Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system          (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23108547

 

Review article: Why do cannabinoid receptors have more than one endogenous ligand? (abst – 2012)                              http://www.ncbi.nlm.nih.gov/pubmed/23108541

 

Review article: The endocannabinoid system in normal and pathological brain ageing (abst – 2012)                            http://www.ncbi.nlm.nih.gov/pubmed/23108550

 

The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-β and in the cortex of aged rats.                                       (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22891244

 

Endocannabinoids at the synapse a decade after the Dies Mirabilis (29 March 2001): what we still do not know.                                       (abst – 2012)       http://www.ncbi.nlm.nih.gov/pubmed/22289914

 

Inhibitors of the Endocannabinoid-Degrading Enzymes, or how to Increase Endocannabinoid’s Activity by Preventing their Hydrolysis.                                       (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22280341

 

Effect of an Acute Consumption of a Moderate Amount of Ethanol on Plasma Endocannabinoid Levels in Humans.                                         (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22278319

 

Equipotent Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase – Dual Targets of the Endocannabinoid System to Protect against Seizure Pathology. (abst – 2012)                             http://www.ncbi.nlm.nih.gov/pubmed/22270809

 

Alteration of endocannabinoid system in human gliomas.          (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22176552

 

Dual inhibition of MAGL and type II topoisomerase by N-phenylmaleimides as a potential strategy to reduce neuroblastoma cell growth.                                        (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22127371

 

Regulation of endocannabinoid release by G proteins: A paracrine mechanism of G protein-coupled receptor action.                                           (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22075205

 

Effect of omega-3 polyunsaturated fatty acids on the endocannabinoid system in osteoblast-like cells and muscle                                 (abst – 2012)  http://docs.lib.purdue.edu/dissertations/AAI3444794/

 

Effects of Peptide and Lipid Endocannabinoids on Arthritic Pain at Spinal Level. (abst – 2012)                               http://www.ncbi.nlm.nih.gov/pubmed/22451592

 

Circulating Endocannabinoid Concentrations and Sexual Arousal in Women. (abst – 2012)                            http://www.ncbi.nlm.nih.gov/pubmed/22462722

 

Essential fatty acids and lipid mediators. Endocannabinoids        (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22730630

 

Stimulation of acumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats.                                    (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22728691

 

Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.                  (abst – 2012)        http://www.ncbi.nlm.nih.gov/pubmed/22280339

 

Long-lasting potentiation of hippocampal synaptic transmission by direct cortical input is mediated via endocannabinoids                                 (abst – 2012)  http://jp.physoc.org/content/590/10/2305.abstract?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=c  annabinoid&searchid=1&FIRSTINDEX=105&sortspec=date&resourcetype=HWCIT

 

THE CO-EXPRESSION OF THE ENDOCANNABINOID SYSTEM AND THE RANK/RANKL SIGNALLING PATHWAY IN HUMAN BONE AND OSTEOCLAST CULTURE           (abst – 2012)

http://www.bjjprocs.boneandjoint.org.uk/content/94-  B/SUPP_XVIII/7.abstract?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=  1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT

 

Photoperiodic Changes in Endocannabinoid Levels and Energetic Responses to Altered Signalling at CB1 Receptors in Siberian Hamsters                                       (abst – 2012)  http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2012.02312.x/abstract

 

The endocannabinoid 2-arachidonoylglicerol decreases calcium induced cytochrome c release from liver mitochondria.                                       (abst – 2012)  http://www.springerlink.com/content/54jm40088728t0pn/

 

2-Arachidonoylglycerol Signaling in Forebrain Regulates Systemic Energy Metabolism (abst – 2012)                                http://www.sciencedirect.com/science/article/pii/S1550413112000526

 

The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models           (abst – 2012)  http://jpet.aspetjournals.org/content/342/1/188.abstract?sid=ae58f15a-06bb-4a81-b850-61bb89fd59f5

 

Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study. (abst – 2012)                               http://www.ncbi.nlm.nih.gov/pubmed/22442280

 

GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors. (abst – 2012)                               http://www.ncbi.nlm.nih.gov/pubmed/22820167

 

Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation.                                       (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22807196

 

The Endocannabinoid System and the Brain.       (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22804774

 

“Redundancy” of endocannabinoid inactivation: new challenges and opportunities for pain control.  (abst – 2012)               http://www.ncbi.nlm.nih.gov/pubmed/22860203

 

Determination of the two major endocannabinoids in human plasma by μ-SPE followed by HPLC-MS/MS.                                    (abst – 2012)          http://www.ncbi.nlm.nih.gov/pubmed/22847477

 

Endocannabinoids reduce cerebral damage after hypoxic-ischemic injury in perinatal rats. (abst – 2012)                              http://www.ncbi.nlm.nih.gov/pubmed/22841538

 

Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists.                                         (abst – 2012)        http://www.ncbi.nlm.nih.gov/pubmed/22990678

 

Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids.

(abst – 2012)       http://www.ncbi.nlm.nih.gov/pubmed/22801993

 

Endocannabinoid system and mood disorders: Priming a target for new therapies. (abst – 2012)                              http://www.ncbi.nlm.nih.gov/pubmed/23261685

 

The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.                          (abst – 2012)        http://www.ncbi.nlm.nih.gov/pubmed/22917662

 

Modulation of sweet responses of taste receptor cells.        (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22947916

 

Effects of parabolic flight and spaceflight on the endocannabinoid system in humans. (abst – 2012)                              http://www.ncbi.nlm.nih.gov/pubmed/23023882

 

Differences in the endocannabinoid system of sperm from fertile and infertile men. (abst – 2012)                           http://www.ncbi.nlm.nih.gov/pubmed/23082196

 

The endocannabinoid system: a key modulator of emotions and cognition     (abst – 2012)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490098/

 

The Volitional Nature of Nicotine Exposure Alters Anandamide and Oleoylethanolamide Levels in the Ventral Tegmental Area.                                  (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23169348

 

Essential fatty acids and lipid mediators. Endocannabinoids          (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22730630

 

Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.        (abst – 2012)                                      http://www.ncbi.nlm.nih.gov/pubmed/23127915

 

2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.                                             (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23242611

 

The evolution and comparative neurobiology of endocannabinoid signaling (abst  – 2012)                                http://www.ncbi.nlm.nih.gov/pubmed/23108540

 

The role of endocannabinoids in gonadal function and fertility along the evolutionary axis.    (abst – 2012)               http://www.ncbi.nlm.nih.gov/pubmed/22305972

 

The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.                          (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22917662?dopt=Abstract

 

Multiple functions of endocannabinoid signaling in the brain.       (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22524785?dopt=Abstract

 

Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy.                                 (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/23206503

 

The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB1 and FAAH-independent mechanisms                                      (abst – 2012)  http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02208.x/abstract

 

Cortisol-mediated adhesion of synovial fibroblasts is dependent on the degradation of anandamide and activation of the endocannabinoid system                                    (abst – 2012)  http://onlinelibrary.wiley.com/doi/10.1002/art.37684/abstract

 

Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans                                 (abst – 2012)       http://www.ncbi.nlm.nih.gov/pubmed/22763622

 

The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear- conditioned analgesia and controls fear expression in the presence of nociceptive tone (abst – 2012)                            http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01478.x/abstract

 

Marijuana cannabinoids found to help combat autism       (news – 2012)

http://www.naturalnews.com/037445_marijuana_cannabinoids_autism.html

 

Marijuana Compound Treats Schizophrenia with Few Side Effects: Clinical Trial (news – 2012)                                  http://www.mhhub.com/archives/16603

 

Marijuana-like brain chemicals could be key to treating fragile X syndrome (news – 2012)

http://www.empowher.com/wellness/content/marijuana-brain-chemicals-could-be-key-treating-fragile-x- syndrome?page=0,2

 

How the endocannabinoid 2-AG may reduce symptoms of ‘Fragile X’ autism (news – 2012)

http://sensiseeds.com/en/blog/how-the-endocannabinoid-2-ag-may-reduce-symptoms-of-fragile-x-autism/

 

Fragile X Model Reveals New Role for the Fragile X Mental Retardation Protein

 

(news – 2012)            http://jaxmice.jax.org/news/2012/Fragile_X_signalosome.html

 

Boosting pot-like chemicals treats fragile X symptoms      (news – 2012)

http://www.universityofcalifornia.edu/news/article/28399

 

Boosting natural marijuana-like brain chemicals treats fragile X syndrome symptoms (news – 2012)                            http://www.today.uci.edu/news/2012/09/nr_fragilex_120920.php

 

Cannnabinoids, Breast Milk, and Development       (news – 2012)

http://www.examiner.com/article/cannnabinoids-breast-milk-and-development

 

Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage.                                           (full – 2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527460/

 

Metabolisms of endocannabinoids and related N-acylethanolamines: Canonical and alternate pathways                                     (full – 2013)       http://onlinelibrary.wiley.com/doi/10.1111/febs.12152/pdf

 

THE ENDOCANNABINOID SYSTEM PROVIDES AN AVENUE FOR EVIDENCE- BASED TREATMENT DEVELOPMENT FOR PTSD                          (1st page – 2013)

http://onlinelibrary.wiley.com/doi/10.1002/da.22031/abstract

 

Aging modifies the enzymatic activities involved in 2-arachidonoylglycerol metabolism. (abst – 2013)                           http://www.ncbi.nlm.nih.gov/pubmed/23281018

 

Involvement of nitric oxide through endocannabinoids release in microglia activation during the course of CNS regeneration in the medicinal leech.                                               (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23355252

 

Taste sensitivity to 6-n-propylthiouracil is associated with endocannabinoid plasma levels in normal-weight individuals.                                       (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23398921

 

The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis.                                      (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23373571

 

Nicotine-Induced Neuroprotection Against Ischemic Injury Involves Activation of Endocannabinoid System in Rats                                       (abst – 2013)  http://link.springer.com/article/10.1007/s11064-012-0927-6

 

Stimulatory and Inhibitory Roles of Brain 2-Arachidonoylglycerol in Bombesin-Induced Central Activation of Adrenomedullary Outflow in Rats.                                         (abst – 2013)  http://www.ncbi.nlm.nih.gov/pubmed/23386378

Share a link for

1 Comment

  1. Thank you for sharing your info. I really appreciate your efforts
    and I will be waiting for your next post thanks once again.

    Feel free to visit my page :: injury attorney drunk driving

Leave a Reply

Your email address will not be published.

*

© 2019 Debbie's Place

Powered by

www.420.ag